3 ms·
While I agree $300 is a ripoff and takes advantage of how medicine works in the US (i.e. the cost for most users is opaque b/c insurance pays) I can also see th
by mc32 10y ago
While I agree $300 is a ripoff and takes advantage of how medicine works in the US (i.e. the cost for most users is opaque b/c insurance pays) I can also see that $30 is not likely a viable price --just like I can put a sandwich together for $3 doesn't mean I can run a profitable sandwich shop selling sandwiches at $3.
As a consumer I could see this for $75 - $100 retail (and some discount to institutional buyers) but $30 is probably not viable and of course $300 is ridiculous.
- iopq 10y agoBut it's profitable to sell sandwiches at $6 - that's the whole point.
- mc32 10y agoIt's only profitable to sell $6 sandwiches if... 1. you use unpaid labor (family) or 2 you have 1,000+ franchisees. If you are low volume, you're gonna have to sell at $8 - $10 to make something worthwhile. Now, I get it, they are unquestionably overcharging for this drug and delivery system. I just don't think you can say that since I can make something at the rock bottom price of $x that someone else should be able to make a living (or run a pharma corp.) by selling at a similar price. The sweet spot is somewhere between $30 and $300, where it is is probably closer to $100.
- iopq 10y agoIf you have 10 customers an hour on average and you pay some guy $10 an hour to make 10 sandwiches, then your costs at $4 per sandwich. That means you have 33% headroom to pay rent for your business, which is better than what McDonald's has. McDonald's has decent pricing because they shoot for like 28% and a lot of volume (much more than 10 customers an hour and probably more hours than your business). A soda machine is basically free money because syrup and water cost pennies. The cup is the most expensive thing you give to the customer for his $1.99 soda.
- mc32 10y agoIt's rent, opportunity cost, insurance, litigation, brand awareness, promotions, etc. Sure a McD can operate at that level because they have efficiencies and have bargaining power and arbitrage. A standalone shop doesn't stand a chance of being economically viable for an independent owner --you don't want a pharma which barely scrapes by. You want healthy ones but not ones which are willing to unjustly take advantage of their customers/patients. Anyway, my main point was that ingredient cost is only one part of the cost of making/delivering something. IIRC, restaurants aim for foodstuffs to amount to 30% or less of sales to be viable.
- iopq 10y agoWell, yeah, a restaurant can buy more ingredients at a time which makes it cheaper since they get a bulk discount. While you pay $3 for that sandwich, the restaurant only pays $1.50. If the DIY EpiPen costs you $30, then a factory probably churn one out for $15.
- mc32 10y agoSo if we're applying restaurant maths to this they might be okay charging $45 or double it to $90 for their proprietary delivery system?
- iopq 10y agoLet's just say some number between $50 and $100 is what a company would charge for it. Someone said the old price was $57, which is right about where our back of the napkin math put it.
- ascorbic 10y agoThe cost of this project includes $28 for buying the insulin autoinjector at retail. There is no way it costs $30 to manufacture. I'd be amazed if they cost $5. Injection moulded plastic is extremely cheap once you've made the moulds.
- prklmn 10y agoThe technology is old and should be priced competitively by now. To just come up with random numbers for a price doesn't make much sense. With your sandwich example - Subway sells $4 sandwiches because they have to, and they make plenty of profit. If they tried to sell the same sandwiches for $14, nobody would buy them and they would be out of business. The same level of competition does not exist with the epipen because of poor legislation and corruption within the FDA. If significant competition existed, epipens would cost very close to $30 or however much they cost to make. There are many viable businesses operating at low margins.
- jellicle 10y agoAutoinjectors for other drugs sell at $33 retail: http://www.buyemp.com/product/meridian-auto-injectors http://www.buyemp.com/product/meridian-auto-injectors They (including epipens) probably cost about $10 to make. That's total cost, from production to delivery to the retail outlet. They would have been handsomely profitable at the old price of $57.
- mc32 10y agoYeah, that seems like a fair take. They'd get away with a little inflation --so $75 - $100 but definitely not $300. That's just opportunistic gouging.
- ascorbic 10y ago> $30 is probably not viable They cost $35 to the NHS in the UK.
- atmosx 10y agoDepends I guess on how you approach healthcare. If healthcare is a business then of course a considerably profitable way of producing a drug is necessary. If healthcare is public service then profitability is not a primary concern. Data-driven decisions shows that approaching healthcare as a public service is much more effective. The choice here is rather obvious, yet for some reason, average people who would benefit immensely from a public health system in the US seems to disregard it as socialist, paying for someone else and so forth. Please note that drug corporations are insanely lucrative in Europe too, so a public health care system doesn't seem to harm drug companies all that much, financially speaking.
- TeMPOraL 10y agoI think the choice is not that obvious if you factor in sustainability. A health system that is all about saving lives but collapses on itself (taking down a chunk of economy with it) within a year or two is not better than a less effective health system that can run sustainably for decades or more. IMO you need to give the drug companies enough money to cover their operating expenses and R&D costs and give some margin to stay afloat. But not more than that. It's hard to do because this aspect is one that is handled well by free market - but in healthcare, you very much care about the thing free market utterly sucks at - product quality. You need regulation to ensure the product is good enough, and many of the important criteria are not immediately verifiable by the customer at the point of sale. Trying to reconcile those two issues is the hard problem.
- omgtehlion 10y agoPlease note that that $27 for autoject also include wide margin in it (manufacturer, distribution, retail, etc). And epinephrine at volume is essentially free, so $30 seems to be a good estimate.